Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion

Journal of Medical Virology

Volumn 74, Issue 2, 2004, Pages 237-245

  Liu, Chun Jen ^a   Chen, Pei Jer ^a   Lai, Ming Yang ^a   Kao, Jia Horng ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Basic core promoter; Hepatitis B virus; Mutant; Precore; Seroreversion; Viral load

Indexed keywords

CORE PROTEIN; DINUCLEOTIDE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASIC CORE PROMOTER; CHRONIC HEPATITIS; COHORT ANALYSIS; DISEASE EXACERBATION; EVOLUTION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSPECTIVE STUDY; REVERTANT; SEQUENCE ANALYSIS; SEROCONVERSION; SEROREVERSION; STOP CODON; VIRUS CARRIER; VIRUS GENOME; VIRUS MUTATION;

HEPATITIS B VIRUS;

EID: 84984584170     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20176     Document Type: Article

References (42)

1. Asahina Y, Izumi N, Uchihara M, Noguchi O, Nishimura Y, Inoue K, Ueda K, Tsuchiya K, Hamano K, Itakura J, Miyake S. 2003. Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C. J Hepatol 39:1063-1069.
2. A mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29:946-953.
3. Brunetto MR, Giarin MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, Serra A. 1991. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88:4186-4190.
4. Brunetto MR, Rodriguez UA, Bonino F. 1999. Hepatitis B virus mutants. Intervirology 42:69-80.
5. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. 1996. Effects of a naturally occurring mutation in the hepatitis virus basal core promoter on precore gene expression and viral replication. J Virol 70:5845-5851.
6. Carman WF, Hadziyannis S, McGarvey MJ, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. 1989. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2:588-590.
7. Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. 2003. Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B. J Clin Microbiol 41:4793-4795.
8. Chen RW, Piiparinen H, Seppanen M, Koskela P, Sarna S, Lappalainen M. 2001. Real-time PCR for the detection and quantitation of hepatitis B virus DNA. J Med Virol 65:250-256.
9. Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY, Kao JH, Chen DS. 2004. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2:64-71.
10. Chu CJ, Hussain M, Lok ASF. 2002. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis C virus genotype C. Gastroenterology 122:1756-1762.
11. Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. 2002. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: Clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol 40:16-21.
12. Davis GL, Hoofnagle JH, Waggoner JG. 1984. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86:230-235.
13. Fattovich G, Brollo L, Alberti A, Realdi G, Pontisso P, Giustina G, Ruol A. 1990. Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis. Liver 10:141-146.
14. Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65-91.
15. Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. 2000. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology 32:635-639.
16. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35:1522-1527.
17. Hunt CM, McGill JM, Allen MI, Condreay LD. 2000. Clinical relevance of hepatitis B viral mutations. Hepatology 31:1037-1044.
18. Kao JH, Chen PJ, Lai MY, Chen DS. 2000a. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554-559.
19. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. 2000b. Hepatitis B genotypes and response to interferon therapy. J Hepatol 33:998-1002.
20. Kao JH, Chen PJ, Lai MY, Chen DS. 2002a. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40:1207-1209.
21. Kao JH, Liu CJ, Chen DS. 2002b. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 36:303-304.
22. Kao JH, Chen PJ, Lai MY, Chen DS. 2002c. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 40:22-25.
23. Kao JH. 2002d. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17:643-650.
24. Kao JH, Chen DS. 2002e. Global control of hepatitis B virus. Lancet Infect Dis 2:395-403.
25. Kao JH, Chen PJ, Lai MY, Chen DS. 2003. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327-334.
26. Kao JH, Chen PJ, Lai MY, Chen DS. 2004. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 72:363-369.
27. Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M. 2004. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy. J Med Virol 72:26-34.
28. Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. 2002. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol 37:283-287.
29. Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH. 2004. Evolution of precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver Int 24:1-7.
30. Lindh M, Andersson AS, Gusdal A. 1997. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scaled analysis using a new genotyping method. J Infect Dis 175:1285-1293.
31. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. 1999. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179:775-782.
32. Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. 2001. Hepatitis B virus variants in patients receiving lamivudine treatment with break-through hepatitis evaluated by serial viral loads and full-length viral sequences. Hepatology 34:583-589.
33. Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan. J Biomed Sci 9:166-170.
34. Liu CJ, Chen PJ, Lai MY, Kao JH, Chang CF, Wu HL, Shau WY, Chen DS. 2003. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 124: 80-90.
35. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. 2004. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 72:545-550.
36. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92:1839-1843.
37. Lok AS, Heathcote EJ, Hoofnagle JH. 2001. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120:1828-1853.
38. Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR. 2000. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol 95:2894-2904.
39. McMahon BJ, Holck P, Bulkow L, Snowball M. 2001. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 135:759-768.
40. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trepo C, Wands J, Tong S. 2003. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77:6601-6612.
41. Perrillo RP, Campbell CR, Sanders GE, Regenstein FG, Bodicky CJ. 1984. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. Ann Intern Med 100:43-46.
42. Proceedings of the Asia-Pacific Consensus Meeting for the Diagnosis and Treatment of Hepatitis B and C. 2000. Kyoto, Japan, 6-7 September 1999. J Gastroenterol Hepatol 15:E1-E193.